Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Diversity in immunogenomics: the value and the challenge

Immunogenomics studies have been largely limited to individuals of European ancestry, restricting the ability to identify variation in human adaptive immune responses across populations. Inclusion of a greater diversity of individuals in immunogenomics studies will substantially enhance our understanding of human immunology.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sirugo, G., Williams, S. M. & Tishkoff, S. A. Cell 177, 1080 (2019).

    Article  CAS  Google Scholar 

  2. Ben-Eghan, C. et al. Nature 585, 184–186 (2020).

    Article  CAS  Google Scholar 

  3. Choudhury, A. et al. Nature 586, 741–748 (2020).

    Article  CAS  Google Scholar 

  4. Retshabile, G. et al. Am. J. Hum. Genet. 102, 731–743 (2018).

    Article  CAS  Google Scholar 

  5. Freeman, J. D., Warren, R. L., Webb, J. R., Nelson, B. H. & Holt, R. A. Genome Res. 19, 1817–1824 (2009).

    Article  CAS  Google Scholar 

  6. Weinstein, J. A., Jiang, N., White, R. A. III, Fisher, D. S. & Quake, S. R. Science 324, 807–810 (2009).

    Article  CAS  Google Scholar 

  7. Boyd, S. D. et al. J. Immunol. 184, 6986–6992 (2010).

    Article  CAS  Google Scholar 

  8. Briney, B., Inderbitzin, A., Joyce, C. & Burton, D. R. Nature 566, 393–397 (2019).

    Article  Google Scholar 

  9. Avnir, Y. et al. Sci. Rep. 6, 20842 (2016).

    Article  CAS  Google Scholar 

  10. Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V. & Chudakov, D. M. Nat. Rev. Immunol. 20, 294–307 (2020).

    Article  CAS  Google Scholar 

  11. Bashford-Rogers, R. J. M. et al. Nature 574, 122–126 (2019).

    Article  CAS  Google Scholar 

  12. Gate, D. et al. Nature 577, 399–404 (2020).

    Article  CAS  Google Scholar 

  13. Singh, K. M. et al. Immunogenetics 64, 97–109 (2012).

    Article  Google Scholar 

  14. Dilthey, A., Cox, C., Iqbal, Z., Nelson, M. R. & McVean, G. Nat. Genet. 47, 682–688 (2015).

    Article  CAS  Google Scholar 

  15. Scheepers, C. et al. J. Immunol. 194, 4371–4378 (2015).

    Article  CAS  Google Scholar 

  16. Watson, C. T. et al. Am. J. Hum. Genet. 92, 530–546 (2013).

    Article  CAS  Google Scholar 

  17. Watson, C. T., Glanville, J. & Marasco, W. A. Trends Immunol. 38, 459–470 (2017).

    Article  CAS  Google Scholar 

  18. Quintana-Murci, L. Cell 177, 184–199 (2019).

    Article  CAS  Google Scholar 

  19. Gadala-Maria, D. et al. Front. Immunol. 10, 129 (2019).

    Article  CAS  Google Scholar 

  20. Ralph, D. K. & Matsen, F. A. IV PLOS Comput. Biol. 15, e1007133 (2019).

    Article  Google Scholar 

  21. Corcoran, M. M. et al. Nat. Commun. 7, 13642 (2016).

    Article  CAS  Google Scholar 

  22. Zhang, W. et al. Front. Immunol. 7, 457 (2016).

    PubMed  PubMed Central  Google Scholar 

  23. Safonova, Y. & Pevzner, P. A. Front. Immunol. 10, 987 (2019).

    Article  CAS  Google Scholar 

  24. Bhardwaj, V., Franceschetti, M., Rao, R., Pevzner, P. A. & Safonova, Y. PLOS Comput. Biol. 16, e1007837 (2020).

    Article  CAS  Google Scholar 

  25. Ohlin, M. et al. Front. Immunol. 10, 435 (2019).

    Article  CAS  Google Scholar 

  26. Rodriguez, O. L. et al. Front. Immunol. 11, 2136 (2020).

    Article  CAS  Google Scholar 

  27. Lefranc, M.-P. et al. Nucleic Acids Res. 43, D413–D422 (2015).

    Article  CAS  Google Scholar 

  28. Christley, S. et al. Front. Big Data 3, 22 (2020).

    Article  Google Scholar 

  29. Burton, D. R. Nat. Rev. Immunol. 19, 77–78 (2019).

    Article  CAS  Google Scholar 

  30. Wang, Y. et al. Immunogenetics 63, 259–265 (2011).

    Article  Google Scholar 

  31. Greiff, V., Yaari, G. & Cowell, L. G. Curr. Opin. Syst. Biol. 24, 109–119 (2020).

    Article  Google Scholar 

  32. Ioannidis, J. P. A., Powe, N. R. & Yancy, C. J. Am. Med. Assoc. 325, 623–624 (2021).

    Article  Google Scholar 

  33. Severe Covid-19 GWAS Group. et al. N. Engl. J. Med 383, 1522–1534 (2020).

    Article  Google Scholar 

  34. Huang, J. et al. Immunity 45, 1108–1121 (2016).

    Article  CAS  Google Scholar 

  35. Robbiani, D. F. et al. Cell 169, 597–609.e11 (2017).

    Article  CAS  Google Scholar 

  36. Yuan, M. et al. Science 369, 1119–1123 (2020).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Nicky Mulder for comments that greatly improved the manuscript. Y.S. was supported by the National Science Foundation EAGER award (no. 2032783). M.S. is supported by Ministry of Science and Higher Education of the Russian Federation grant no. 075-15-2020-807. A.B.P. and C.D.B. are supported by an award from the National Human Genome Research Institute of the National Institutes of Health (U41HG009649). C.T.W. and O.L.R. are supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R24AI138963 and R21AI142590. V.G. is supported by a UiO World-Leading Research Community grant, the UiO:LifeScience Convergence Environment Immunolingo, EU Horizon 2020 iReceptorplus (no. 825821) and a Research Council of Norway FRIPRO project (#300740). V.D.J. was supported by an award from the National Cancer Institute of the National Institutes of Health (K12CA001727). The laboratory of L.Q.-M. is supported by the Institut Pasteur, the Collège de France, the CNRS, the Fondation Allianz-Institut de France and the French Government’s Investissement d’Avenir program, Laboratoires d’Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (ANR-10- LABX-62-IBEID) and ‘Milieu Intérieur’ (ANR-10-LABX-69-01). R.A.A. is supported by the Fogarty International Center of the National Institute of Health under award number D43TW010934. P.K. is supported by the Bill and Melinda Gates Foundation (OPP1113682), National Institute of Allergy and Infectious Diseases (NIAID) (1U19AI109662, U19AI057229, 5R01AI125197), Department of Defense (W81XWH1910235) and Catalyst and Transformational Awards from the Dr. Ralph & Marian Falk Medical Research Trust. C.S. is supported by NIAID of the National Institutes of Health under award number U01AI136677. G.K.H is supported by a grant from the Swedish Research Council (award number 532 2017-00968). S.M. is partially supported by National Science Foundation grants 2041984.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serghei Mangul.

Ethics declarations

Competing interests

V.G. declares advisory board positions in aiNET GmbH and Enpicom B.V. P.K. is a co-founder of Inflammatix, Inc. He is also a consultant to Inflammatix, Inc., Vir Biotechnology, Cepheid, and Genentech. G.K.H and M.C. are founders of ImmuneDiscover Sweden AB.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, K., Safonova, Y., Shugay, M. et al. Diversity in immunogenomics: the value and the challenge. Nat Methods 18, 588–591 (2021). https://doi.org/10.1038/s41592-021-01169-5

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41592-021-01169-5

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing